Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312337 | SCV000846418 | benign | Inborn genetic diseases | 2016-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000968781 | SCV001116255 | benign | Neuronal ceroid lipofuscinosis 13 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001662786 | SCV001873820 | benign | not provided | 2019-08-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001662786 | SCV005318629 | benign | not provided | criteria provided, single submitter | not provided |